{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:58:56Z","timestamp":1792205936008,"version":"4.4.0"},"reference-count":83,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Sub-Saharan Africa has the highest burden of malaria in the world. Artemisinin-based combination therapies (ACTs) have been the cornerstone in the efforts to reduce the global burden of malaria. In the effort to facilitate early detection of resistance for artemisinin derivatives and partner drugs, WHO recommends monitoring of ACT\u2019s efficacy in the malaria endemic countries. The present systematic meta-analysis study summarises the evidence of therapeutic efficacy of the commonly used artemisinin-based combinations for the treatment of uncomplicated <jats:italic>P<\/jats:italic>. <jats:italic>falciparum<\/jats:italic> malaria in Sub-Saharan Africa after more than a decade since the introduction of the drugs.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Fifty two studies carried out from 2010 to 2020 on the efficacy of artemether-lumefantrine or dihydro-artemisinin piperaquine or artesunate amodiaquine in patients with uncomplicated <jats:italic>P<\/jats:italic>. <jats:italic>falciparum<\/jats:italic> malaria in Sub-Saharan Africa were searched for using the Google Scholar, Cochrane Central Register of controlled trials (CENTRAL), PubMed, Medline, LILACS, and EMBASE online data bases. Data was extracted by two independent reviewers. Random analysis effect was performed in STATA 13. Heterogeneity was established using I<jats:sup>2<\/jats:sup> statistics.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Based on per protocol analysis, unadjusted cure rates in malaria infected patients treated with artemether-lumefantrine (ALU), artesunate-amodiaquine (ASAQ) and dihydroartemisinin-piperaquine (DHP) were 89%, 94% and 91% respectively. However, the cure rates after PCR correction were 98% for ALU, 99% for ASAQ and 99% for DHP.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The present meta-analysis reports the overall high malaria treatment success for artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine above the WHO threshold value in Sub-Saharan Africa.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0264339","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T18:43:26Z","timestamp":1646937806000},"page":"e0264339","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":61,"title":["Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5237-2904","authenticated-orcid":true,"given":"Karol","family":"Marwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Kapesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Baraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Konje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Kidenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Mukonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erasmus","family":"Kamugisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gote","family":"Swedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"pone.0264339.ref001","unstructured":"Organization WH. World malaria report 2020: 20 years of global progress and challenges. World malaria report 2020: 20 years of global progress and challenges2020."},{"key":"pone.0264339.ref002","unstructured":"Organization WH. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019). 2020."},{"issue":"10","key":"pone.0264339.ref003","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","article-title":"Antimalarial drug resistance in Africa: the calm before the storm?","volume":"19","author":"MD Conrad","year":"2019","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"pone.0264339.ref004","first-page":"1","article-title":"Return of chloroquine sensitivity to Africa? Surveillance of African Plasmodium falciparum chloroquine resistance through malaria imported to China","volume":"10","author":"F Lu","year":"2017","journal-title":"Parasites & vectors"},{"key":"pone.0264339.ref005","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820003167","article-title":"Efficacy of artemisinin\u2013lumefantrine for treatment of uncomplicated malaria after more than a decade of its use in Kenya","volume":"149","author":"G Kishoyian","year":"2021","journal-title":"Epidemiology & Infection"},{"key":"pone.0264339.ref006","unstructured":"WHO. World malaria report 2020: 20 years of global progress and challenges. World Health Organization Geneva; 2020."},{"key":"pone.0264339.ref007","unstructured":"Soe AP. Treatment efficacy of artesunate-amodiaquine and prevalence of Plasmodium falciparum drug resistance markers in Zanzibar, 2002\u20132017. 2019."},{"key":"pone.0264339.ref008","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","author":"A Uwimana","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0264339.ref009","doi-asserted-by":"crossref","first-page":"e08714","DOI":"10.7554\/eLife.08714","article-title":"Genomic epidemiology of artemisinin resistant malaria","volume":"5","author":"Project MPfC","year":"2016","journal-title":"elife"},{"issue":"8","key":"pone.0264339.ref010","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3201\/eid2408.180370","article-title":"Plasmodium falciparum plasmepsin 2 duplications, West Africa","volume":"24","author":"J Inoue","year":"2018","journal-title":"Emerging infectious diseases"},{"issue":"1","key":"pone.0264339.ref011","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12936-016-1569-y","article-title":"Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand","volume":"15","author":"S Chaorattanakawee","year":"2016","journal-title":"Malaria journal"},{"issue":"6","key":"pone.0264339.ref012","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s15010-018-1174-9","article-title":"Dihydroartemisinin\u2013piperaquine treatment failure in uncomplicated Plasmodium falciparum malaria case imported from Ethiopia","volume":"46","author":"G Russo","year":"2018","journal-title":"Infection"},{"issue":"12","key":"pone.0264339.ref013","doi-asserted-by":"crossref","first-page":"e01516","DOI":"10.1128\/AAC.01516-17","article-title":"Changing antimalarial drug sensitivities in Uganda","volume":"61","author":"SA Rasmussen","year":"2017","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"1","key":"pone.0264339.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-2756-4","article-title":"African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker","volume":"18","author":"D Leroy","year":"2019","journal-title":"Malaria journal"},{"issue":"11","key":"pone.0264339.ref015","doi-asserted-by":"crossref","first-page":"e26005","DOI":"10.1371\/journal.pone.0026005","article-title":"Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast","volume":"6","author":"S Borrmann","year":"2011","journal-title":"PloS one"},{"issue":"7","key":"pone.0264339.ref016","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3201\/eid2107.150213","article-title":"Slow clearance of Plasmodium falciparum in severe pediatric malaria, Uganda, 2011\u20132013","volume":"21","author":"M Hawkes","year":"2015","journal-title":"Emerging infectious diseases"},{"issue":"1","key":"pone.0264339.ref017","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12936-015-1018-3","article-title":"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola","volume":"14","author":"K Kiaco","year":"2015","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03446-8","article-title":"Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991\u20132019","volume":"19","author":"G Rathmes","year":"2020","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Systematic reviews"},{"issue":"2","key":"pone.0264339.ref020","doi-asserted-by":"crossref","DOI":"10.4314\/ajid.v4i2.55149","article-title":"Artesunate plus Amodiaquine (AS+ AQ) versus Artemether-Lumefantrine (AL) for the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa-a meta-analysis","volume":"4","author":"SO Bello","year":"2010","journal-title":"African journal of infectious diseases"},{"key":"pone.0264339.ref021","unstructured":"Health NIo. National Heart Lung, and Blood Institute. Study quality assessment tools. National Institutes of Health: Bethesda, MD, USA; 2018."},{"key":"pone.0264339.ref022","unstructured":"Organization WH. Methods for surveillance of antimalarial drug efficacy. 2009. 2015."},{"key":"pone.0264339.ref023","doi-asserted-by":"crossref","first-page":"f4040","DOI":"10.1136\/bmj.f4040","article-title":"Meta-analyses: heterogeneity and subgroup analysis","volume":"346","author":"P. Sedgwick","year":"2013","journal-title":"Bmj"},{"issue":"1","key":"pone.0264339.ref024","first-page":"1","article-title":"Pyronaridine\u2013artesunate and artemether\u2013lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial","volume":"17","author":"JM Roth","year":"2018","journal-title":"Malaria journal"},{"issue":"6","key":"pone.0264339.ref025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/trstmh\/trz009","article-title":"Efficacy of artemether\u2013lumefantrine versus dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial","volume":"113","author":"A Uwimana","year":"2019","journal-title":"Transactions of The Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"pone.0264339.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-2730-1","article-title":"Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania","volume":"18","author":"DS Ishengoma","year":"2019","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref027","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12936-016-1091-2","article-title":"Therapeutic efficacy of artemether\u2013lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin","volume":"15","author":"A Ogouyemi-Hounto","year":"2016","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-016-1444-x","article-title":"In vivo efficacy of artesunate\u2013amodiaquine and artemether\u2013lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo","volume":"15","author":"M de Wit","year":"2016","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref029","article-title":"Efficacy and tolerability of artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at two sentinel sites across C\u00f4te d\u2019Ivore","volume":"64","author":"A Konat\u00e9","year":"2018","journal-title":"Annals of parasitology"},{"key":"pone.0264339.ref030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.actatropica.2017.03.032","article-title":"Efficacy and safety of artemether\u2013lumefantrine for the treatment of uncomplicated falciparum malaria at sentinel sites in Mozambique, 2015","volume":"171","author":"C Salvador","year":"2017","journal-title":"Acta tropica"},{"issue":"1","key":"pone.0264339.ref031","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12936-015-1078-4","article-title":"Malaria burden and anti-malarial drug efficacy in Owando, northern Congo","volume":"15","author":"BP Singana","year":"2016","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-018-2200-1","article-title":"Efficacy of artesunate\u2013amodiaquine, dihydroartemisinin\u2013piperaquine and artemether\u2013lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger","volume":"17","author":"F Grandesso","year":"2018","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-016-1381-8","article-title":"Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012\u20132013","volume":"15","author":"AM Dorkenoo","year":"2016","journal-title":"Malaria journal"},{"issue":"4","key":"pone.0264339.ref034","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2478\/s11686-019-00115-y","article-title":"Persistence of High In Vivo Efficacy and Safety of Artesunate\u2013Amodiaquine and Artemether\u2013Lumefantrine as the First-and Second-Line Treatments for Uncomplicated Plasmodium falciparum Malaria 10 Years After Their Implementation in Gabon","volume":"64","author":"JMN Ngomo","year":"2019","journal-title":"Acta Parasitologica"},{"issue":"1","key":"pone.0264339.ref035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12936-016-1281-y","article-title":"In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014","volume":"15","author":"M Paczkowski","year":"2016","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-3015-4","article-title":"Monitoring of efficacy, tolerability and safety of artemether\u2013lumefantrine and artesunate\u2013amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambar\u00e9n\u00e9, Gabon: an open-label clinical trial","volume":"18","author":"BR Adegbite","year":"2019","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref037","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/1475-2875-13-309","article-title":"In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique","volume":"13","author":"A Nhama","year":"2014","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref038","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12936-018-2524-x","article-title":"Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania","volume":"17","author":"MA Kakolwa","year":"2018","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref039","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12936-018-2409-z","article-title":"High efficacy of artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania","volume":"17","author":"CI Mandara","year":"2018","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1475-2875-12-254","article-title":"A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya","volume":"12","author":"A Agarwal","year":"2013","journal-title":"Malaria journal"},{"issue":"3","key":"pone.0264339.ref041","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4269\/ajtmh.18-0115","article-title":"Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children ten years following adoption as first-line antimalarials","volume":"99","author":"JC Ebenebe","year":"2018","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"1","key":"pone.0264339.ref042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-11-58","article-title":"Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania","volume":"11","author":"E Kamugisha","year":"2012","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-13-376","article-title":"Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania","volume":"13","author":"A Shayo","year":"2014","journal-title":"Malaria Journal"},{"issue":"1","key":"pone.0264339.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-11-388","article-title":"Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana","volume":"11","author":"B Abuaku","year":"2012","journal-title":"Malaria journal"},{"issue":"6","key":"pone.0264339.ref045","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.4269\/ajtmh.20-0852","article-title":"Therapeutic Efficacy of Artemether\u2013Lumefantrine for Uncomplicated Falciparum Malaria in Northern Zambia","volume":"103","author":"MM Ippolito","year":"2020","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"pone.0264339.ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-1080-x","article-title":"Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations in the treatment of uncomplicated malaria in two ecological zones in Ghana","volume":"15","author":"B Abuaku","year":"2016","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0918-6","article-title":"Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study","volume":"14","author":"M Ndounga","year":"2015","journal-title":"Malaria journal"},{"issue":"9","key":"pone.0264339.ref048","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1128\/AAC.02682-14","article-title":"Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo","volume":"58","author":"M Onyamboko","year":"2014","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"pone.0264339.ref049","author":"Y Diarra","year":"2020","journal-title":"Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015\u20132016"},{"issue":"12","key":"pone.0264339.ref050","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3855\/jidc.3058","article-title":"Efficacy of artemisinin combination therapy for the treatment of uncomplicated falciparum malaria in Nigerian children","volume":"7","author":"O Ojurongbe","year":"2013","journal-title":"The Journal of Infection in Developing Countries"},{"key":"pone.0264339.ref051","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.actatropica.2018.06.016","article-title":"Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone","volume":"185","author":"SJ Smith","year":"2018","journal-title":"Acta tropica"},{"issue":"1","key":"pone.0264339.ref052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-2864-1","article-title":"High therapeutic efficacy of artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated falciparum malaria in Somalia","volume":"18","author":"M Warsame","year":"2019","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0744-x","article-title":"Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem\u00ae) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study","volume":"14","author":"YA Ebstie","year":"2015","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref054","first-page":"1","article-title":"Adding a single low-dose of primaquine (0.25 mg\/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial","volume":"15","author":"R Mwaiswelo","year":"2016","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0826-9","article-title":"Efficacy of artemether\u2013lumefantrine therapy for the treatment of uncomplicated Plasmodium falciparum malaria in Southwestern Ethiopia","volume":"14","author":"SK Mekonnen","year":"2015","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-598","article-title":"Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance","volume":"13","author":"K Sylla","year":"2013","journal-title":"BMC infectious diseases"},{"issue":"1","key":"pone.0264339.ref057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03307-4","article-title":"Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Chewaka District, Ethiopia","volume":"19","author":"A Abamecha","year":"2020","journal-title":"Malaria Journal"},{"key":"pone.0264339.ref058","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2147\/TCRM.S113603","article-title":"Open-label trial on efficacy of artemether\/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia","volume":"12","author":"F Wudneh","year":"2016","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"pone.0264339.ref059","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2020.35.68.20849","article-title":"Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change","volume":"35","author":"I Zongo","year":"2020","journal-title":"The Pan African Medical Journal"},{"issue":"1","key":"pone.0264339.ref060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0775-3","article-title":"Therapeutic efficacy of artemether\u2013lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Enfranze, north-west Ethiopia","volume":"14","author":"G Getnet","year":"2015","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-018-2496-x","article-title":"A randomized trial of dihydroartemisinin\u2013piperaquine versus artemether\u2013lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali","volume":"17","author":"S Dama","year":"2018","journal-title":"Malaria journal"},{"issue":"4","key":"pone.0264339.ref062","doi-asserted-by":"crossref","first-page":"e0176004","DOI":"10.1371\/journal.pone.0176004","article-title":"Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia","volume":"12","author":"M Teklemariam","year":"2017","journal-title":"Plos one"},{"issue":"1","key":"pone.0264339.ref063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-1018-3","article-title":"Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola","volume":"14","author":"K Kiaco","year":"2015","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-016-1339-x","article-title":"High efficacy of artemether-lumefantrine and declining efficacy of artesunate+ sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010\u20132015): evidence from in vivo and molecular marker studies","volume":"15","author":"AA Adeel","year":"2016","journal-title":"Malaria journal"},{"key":"pone.0264339.ref065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/TCRM.S127571","article-title":"In vivo efficacy of artemether\u2013lumefantrine against uncomplicated Plasmodium falciparum malaria in Dembia District, northwest ethiopia","volume":"13","author":"T Deressa","year":"2017","journal-title":"Therapeutics and clinical risk management"},{"key":"pone.0264339.ref066","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/878132","article-title":"Efficacy and safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sentinel sites across C\u00f4te d\u2019Ivoire","volume":"2015","author":"W Yavo","year":"2015","journal-title":"Malaria research and treatment"},{"issue":"3","key":"pone.0264339.ref067","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4269\/ajtmh.15-0503","article-title":"In Vivo Efficacy and Parasite Clearance of Artesunate+ Sulfadoxine\u2013Pyrimethamine Versus Artemether\u2013Lumefantrine in Mali","volume":"94","author":"K Niar\u00e9","year":"2016","journal-title":"The American journal of tropical medicine and hygiene"},{"issue":"1","key":"pone.0264339.ref068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-13-32","article-title":"Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria","volume":"13","author":"MK Muhindo","year":"2014","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0843-8","article-title":"Effectiveness and safety of artemether\u2013lumefantrine versus artesunate\u2013amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial","volume":"14","author":"P Sondo","year":"2015","journal-title":"Malaria journal"},{"issue":"4","key":"pone.0264339.ref070","doi-asserted-by":"crossref","first-page":"e0154618","DOI":"10.1371\/journal.pone.0154618","article-title":"Therapeutic efficacy of artemether-lumefantrine (Coartem\u00ae) in treating uncomplicated P. falciparum malaria in Metehara, Eastern Ethiopia: regulatory clinical study","volume":"11","author":"D Nega","year":"2016","journal-title":"Plos one"},{"issue":"1","key":"pone.0264339.ref071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-1817-9","article-title":"Efficacies of DHA\u2013PPQ and AS\/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in Sudan","volume":"16","author":"AO Mohamed","year":"2017","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-13-496","article-title":"Efficacy of artesunate-amodiaquine for the treatment of acute uncomplicated falciparum malaria in southern Mauritania","volume":"13","author":"M Ouldabdallahi","year":"2014","journal-title":"Malaria journal"},{"issue":"1","key":"pone.0264339.ref073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-2740-z","article-title":"High cure rates and tolerability of artesunate\u2013amodiaquine and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania","volume":"18","author":"CI Mandara","year":"2019","journal-title":"Malaria journal"},{"issue":"9","key":"pone.0264339.ref074","doi-asserted-by":"crossref","first-page":"e0161495","DOI":"10.1371\/journal.pone.0161495","article-title":"Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum Malaria in Children Aged Less than 15 Years in Guinea-Bissau\u2013An Open-Label Non-Inferiority Randomised Clinical Trial","volume":"11","author":"J Ursing","year":"2016","journal-title":"PloS one"},{"issue":"1","key":"pone.0264339.ref075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-018-2290-9","article-title":"Efficacy and safety of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017","volume":"17","author":"E Davlantes","year":"2018","journal-title":"Malaria journal"},{"issue":"12","key":"pone.0264339.ref076","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01067-19","article-title":"No evidence of Plasmodium falciparum k13 artemisinin resistance-conferring mutations over a 24-year analysis in coastal Kenya but a near complete reversion to chloroquine-sensitive parasites","volume":"63","author":"K Wamae","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"pone.0264339.ref077","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"A Uwimana","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"pone.0264339.ref078","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-020-03157-0","article-title":"Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda","volume":"19","author":"B Balikagala","year":"2020","journal-title":"Malaria Journal"},{"issue":"8","key":"pone.0264339.ref079","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3201\/eid2608.191547","article-title":"Increased sensitivity of Plasmodium falciparum to artesunate\/amodiaquine despite 14 years as first-line malaria treatment, Zanzibar","volume":"26","author":"M Msellem","year":"2020","journal-title":"Emerging Infectious Diseases"},{"issue":"1","key":"pone.0264339.ref080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-3031-4","article-title":"En-route to the \u2018elimination\u2019of genotypic chloroquine resistance in Western and Southern Zambia, 14 years after chloroquine withdrawal","volume":"18","author":"L Sitali","year":"2019","journal-title":"Malaria Journal"},{"issue":"10","key":"pone.0264339.ref081","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1128\/AAC.00920-16","article-title":"Intermittent preventive treatment with dihydroartemisinin-piperaquine in Ugandan schoolchildren selects for Plasmodium falciparum transporter polymorphisms that modify drug sensitivity","volume":"60","author":"JI Nankabirwa","year":"2016","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"2","key":"pone.0264339.ref082","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trstmh.2006.07.001","article-title":"Amodiaquine combined with sulfadoxine\/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis","volume":"101","author":"CO Obonyo","year":"2007","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"pone.0264339.ref083","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1475-2875-8-203","article-title":"Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis","volume":"8","author":"J Zwang","year":"2009","journal-title":"Malaria journal"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T18:44:55Z","timestamp":1646937895000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0264339"}},"subtitle":[],"editor":[{"given":"Lucy C.","family":"Okell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":83,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0264339","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}